[The bids for the seventh batch of high-value medical consumables were opened in the morning. Boston Scientific, Olympus, Nanwei Medical, etc. compete for 23 types of digestive interventional consumables] September 10th, this morning, the seventh batch of high-value medical consumables organized by the national organization to purchase in Tianjin started on-site to receive quotation materials. Traditional foreign giants such as Boston Scientific, Olympus, Cook, and Elb, as well as representatives from domestic leading manufacturers such as Nanwei Medical, Aegis, and Jiuhong Medical, entered the venue one after another. The quotation information disclosure meeting will begin at 9:30. It is reported that the products purchased this time cover the main aspects of digestive endoscopy treatment, including balloon dilatation catheters, esophageal and intestinal stents, digestive tract guidewires and other categories. According to the procurement documents, this national procurement of consumables is based on the idea of ​​dispersion management and control of drug centralized procurement, setting up double standard deviation anchor points, and setting up three differentiated selection paths: Rule 1 for direct selection, Rule 2 for resurrection with quantity, and Rule 3 for resurrection without quantity. Multi-dimensional product feature conversion coefficients are also introduced to control prices while taking into account the clinical suitability of the product. The National Medical Insurance Administration recently emphasized that centralized procurement will adhere to "stabilizing clinical practice, ensuring quality, resisting involution, and preventing bid rigging" and guide fair and rational competition in the industry through "excessive prices will lead to elimination, and abnormally low prices without volume" will guide the industry's fair and rational competition. (Reporters Lu Afeng and Wu Chao)